Because these are transporters of endogenous metabolites and drugs—and, in the case of SLC22A6, SLC22A8, SLC22A12, established drug targets—these observations are of interest from both the viewpoint of cancer biology and therapeutics [50]. Here, SLC22A8 is linked to cancer.